Click here to view cell apoptosis assay products
×

Recombinant Human CCL4 protein(His Tag)

Uniprot : P13236
  • Cat.No.:PKSH034170

  • Expression host: E.coli

To Purchase PKSH034170

Size:
  • 20μg
  • 100μg
Price: $249
Qty:

Description

Synonyms MIP-1b: Macrophage Inflammatory Protein-1β;ACT-2
Species Human
Expression_host E.coli
Sequence Ala 24-Asn 92
Accession P13236
Mol_Mass 7.8 kDa
AP_Mol_Mass 11 kDa
Tag None
Bio_Activity Measure by its ability to chemoattract BaF3 cells transfected with human CCR5.The ED50 for this effect is <10 ng/mL.

Properties

Purity > 98 % as determined by reducing SDS-PAGE.
Endotoxin level < 0.1 EU per μg of the protein as determined by the LAL method.
Storage Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Shipping This product is provided as lyophilized powder which is shipped with ice packs.
Formulation Lyophilized from sterile 50 mM Tris, 150 mM NaCl, pH 8.5.
Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Reconstitution Please refer to the printed manual for detailed information.

Background

CCL4 (C-C chemokine ligand 4), is a macrophage inflammatory protein with a chief effect in inflammation and immune-regulation, and was documented in cancer progression by promoting instability in the tumor environment. The inflammatory chemokine (C-C motif) ligand 4 (CCL4) plays an important role in the pathogenesis and progression of cancer. In particular, higher serum CCL4 levels in patients with oral squamous cell carcinoma (OSCC) are associated with a more advanced stage of disease. CCL4 may be a new molecular therapeutic target for inhibition of lymphangiogenesis and metastasis in OSCC. CCL3 and CCL4 loci may be marker SNPs for risk of HCV treatment outcome. CCL4 can enhance the recruitment of preosteoclasts to bone in the early stage, and the reduction of CCR5 promotes osteoclastogenesis when RANKL is prevalent.

Citations

Reviews/Q&A

  • Show all
  • Reviews
  • Q&A
... Show All Show Less

People Also Bought

Apply for
*Product Name:
*Catalog Number:
*Name:
*Email:
*Message:
*Country:
*When will you use it?

*Captcha: